Table 3 Comparison of clinical characteristics with miRNAs expression in serum samples
From: Identification of serum MiRNAs as candidate biomarkers for non-small cell lung cancer diagnosis
Characteristics | Number | miR-3149 | miR-4769.3p | ||||
|---|---|---|---|---|---|---|---|
mean (range) | Z score | p value | mean (range) | Z score | p value | ||
Disease status | Â | Â | Â | Â | Â | Â | Â |
 Cancer | 78 | 0.596 (0.374–0.885) | 6.051 |  < 0.001 | 0.711 (0.442–1.128) | 4.329 |  < 0.001 |
 Noncancerous | 44 | 0.220 (0.116–0.374) |  |  | 0.207 (0.088–0.834) |  |  |
Histological type | Â | Â | Â | Â | Â | Â | Â |
 SCC | 40 | 0.632 (0.376–1.117) | 1.13 | 0.259 | 0.788 (0.452–1.101) | 0.58 | 0.562 |
 ADC | 38 | 0.492 (0.371–0.829) |  |  | 0.662 (0.428–1.194) |  |  |
Tumor stage | Â | Â | Â | Â | Â | Â | Â |
 I + II | 20 | 0.521 (0.386–0.780) | 0.698 | 0.485 | 0.839 (0.622–1.217) | 1.305 | 0.192 |
 III + IV | 58 | 0.616 (0.357–1.107) |  |  | 0.681 (0.370–1.110) |  |  |